Abstract |
Ecdisten, the drug designed on the basis of the phytoecdisteroid ecdisterone isolated from Rhaponticum carthamoides, was used in the treatment of first diagnosed (primary) and persistent (resistant to traditional lambliacides) lambliasis. A control group received metronidazole. Daily parasitological monitoring of lamblia elimination while treating with ecdisten in a daily dose of 20 mg for 10 days indicated the absence of lamblia in 70% of the patients with primary lambliasis on days 3 to 5; in the remaining 30%, parasitic elimination was accomplished on days 6-7 of treatment. In the patients with persistent lambliasis, the parasites were eliminated in 43.2% of cases on days 4-5 and in 56.6% on days 6-10. Metronidazole just on the second day of therapy caused parasitic elimination in 28.6% of the patients. All the patients were freed from lamblia within 5 days. Improvement occurred more rapidly with ecdisten treatment; immunological normalization was seen when ecdisten was used. Seven-ten-day course of ecdisten is sufficient for the treatment of primary lambliasis; when persistent lambliasis is treated, its course should be prolonged. If required, the course may be repeated, by increasing the daily dose.
|
Authors | Zh I Islamova, V N Syrov, Z A Khushbaktova, S O Osipova |
Journal | Meditsinskaia parazitologiia i parazitarnye bolezni
(Med Parazitol (Mosk))
2010 Apr-Jun
Issue 2
Pg. 14-7
ISSN: 0025-8326 [Print] Russia (Federation) |
PMID | 20614521
(Publication Type: Comparative Study, Controlled Clinical Trial, Journal Article)
|
Chemical References |
- Antiprotozoal Agents
- Plant Extracts
- Steroids
- Metronidazole
- ecdystene
|
Topics |
- Adult
- Animals
- Antiprotozoal Agents
(administration & dosage, therapeutic use)
- Chronic Disease
- Drug Administration Schedule
- Giardia
(isolation & purification)
- Giardiasis
(drug therapy)
- Humans
- Leuzea
- Metronidazole
(administration & dosage, therapeutic use)
- Middle Aged
- Plant Extracts
(administration & dosage, therapeutic use)
- Steroids
(administration & dosage, therapeutic use)
- Treatment Outcome
- Young Adult
|